The “Venture Capital for Life-Science BioTech” event, held on January 22, 2025, at Fondazione UNIMI, showcas...
Biotech: Angelini Ventures Leads €20 Million Financing Round for NeumirnaNeumirna Therapeutics: Pioneering RNA-Based Therapies for Neurological Disorders
Neumirna Therapeutics, a Danish biotechnology company specializing in RNA-based therapies for next-generation treatments...